TABLE 1.
Species and strain | Description | Reference or source |
---|---|---|
S. aureus | ||
ATCC 35556 (SA113) | Laboratory strain, biofilm proficient | 23; ATCC |
NCTC 8325 (NRS-77) | Laboratory strain | 36; NARSA |
MW2 (NRS-123) | CA-MRSA, USA 400b | 1; NARSA |
MSSA | Clinical isolate, osteomyelitis | 3 |
MRSA-14234 | Clinical isolate, CA-MRSA | University of Massachusetts Medical Center, Worcesterc |
MRSA-22733 | Clinical isolate, CA-MRSA | |
MRSA-23542 | Clinical isolate, CA-MRSA, USA 300b | |
MRSA-24102 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-24209 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-27687 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-33548 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-35392 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-38230 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-43349 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-44081 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-47263 | Clinical isolate, HA-MRSA, USA 100 | |
MRSA-49404 | Clinical isolate, CA-MRSA, USA 300 | |
MRSA-58336 | Clinical isolate, HA-MRSA, USA 100b | |
MRSA-1094 | Clinical isolate, HA-MRSA, USA 100 | |
ATCC 35556 (pAJ22) | pAJ22 constitutively expresses β-galactosidase encoded by lacZ | 39, this study |
SA113 Δica::Tc | PNAG deficient | 10 |
ATCC 35556 ΔatlA-atlR::erm | Deficient in major autolysin | This study |
S. epidermidis | ||
18972 | Clinical isolate, endocarditis, MRSE | Oscient Pharmaceuticals, Waltham, MA |
1457 | 26 | |
O-47 | 19 | |
ATCC 35984 (RP62A) | 5; ATCC | |
CoNS | ||
WTBF-40 | Clinical isolate | University of Massachusetts Medical Center, Worcester |
WTBF-41 | Clinical isolate | |
WTBF-45 | Clinical isolate | |
WTBF-46 | Clinical isolate | |
WTBF-47 | Clinical isolate | |
WTBF-48 | Clinical isolate | |
E. faecalis | ||
ATCC 51299 | Clinical isolate, VRE | ATCC |
ATCC 51575 | ATCC | |
F317 | Clinical isolate, VRE | Northwestern Memorial Hospital, Chicago, ILd |
F177 | Clinical isolate, VRE | |
F217 | Clinical isolate, VRE | |
E. faecium | ||
EF208 | Clinical isolate, VRE | |
1401 | Clinical isolate, VRE | |
EF1509 | Clinical isolate, VRE | |
F118 | Clinical isolate, VRE | |
E. gallinarum 2392 | Clinical isolate, VRE | |
E. coli ATCC 25922 | Reference strain, biofilm proficient | ATCC |
P. aeruginosa PAO1 | Laboratory strain, biofilm proficient | 51 |
Abbreviations: NARSA, Network on Antibiotic Resistance in Staphylococcus aureus (Chantilly, VA); CA, community acquired; HA, hospital acquired; MRSE, methicillin-resistant S. epidermidis.
The USA 400, USA300, and USA100 designations of MRSA refer to distinct genetic lineages assigned on the basis of pulsed-field gel electrophoresis analyses (31).
Clinical strains of MRSA and CoNS strains were selected from the collection at the University of Massachusetts Medical Center, Worcester, and kindly provided by Richard Ellison.
Clinical strains of VRE were selected from the collection at Northwestern Memorial Hospital, Chicago, IL, and were provided by Jason Pryztwoski.